You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global Tissue Plasminogen Activator Market Research Report 2021 Professional Edition

Tissue plasminogen activator (abbreviated tPA or PLAT) is a protein involved in the breakdown of blood clots. It is a serine protease found on endothelial cells, the cells that line the blood vessels. As an enzyme, it catalyzes the conversion of plasminogen to plasmin, the major enzyme responsible for clot breakdown. Human tPA has a molecular weight of ~70 kDa in the single-chain form.
Market Analysis and Insights: Global Tissue Plasminogen Activator Market
The global Tissue Plasminogen Activator market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Tissue Plasminogen Activator Scope and Segment
The global Tissue Plasminogen Activator market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tissue Plasminogen Activator market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Tissue-type
Urokinase-type
By the end users/application, this report covers the following segments
Ischemic Stroke
Pulmonary Embolism
Myocardial Infarction
Others
Competitive Landscape:
The report provides a list of all the key players in the Tissue Plasminogen Activator market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Tissue Plasminogen Activator key manufacturers in this market include:
Bayer AG
Genentech
Sigma-Aldrich
Taj Pharmaceuticals
Zydus Cadila Healthcare
Calbiochem
1 Tissue Plasminogen Activator Market Overview
1.1 Tissue Plasminogen Activator Product Overview
1.2 Tissue Plasminogen Activator Market Segment by Type
1.2.1 Tissue-type
1.2.2 Urokinase-type
1.3 Global Tissue Plasminogen Activator Market Size by Type
1.3.1 Global Tissue Plasminogen Activator Market Size Overview by Type (2016-2027)
1.3.2 Global Tissue Plasminogen Activator Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Tissue Plasminogen Activator Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Tissue Plasminogen Activator Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Tissue Plasminogen Activator Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Tissue Plasminogen Activator Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Tissue Plasminogen Activator Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Tissue Plasminogen Activator Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Tissue Plasminogen Activator Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Tissue Plasminogen Activator Sales Breakdown by Type (2016-2021)
1.4.2 Europe Tissue Plasminogen Activator Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Tissue Plasminogen Activator Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Tissue Plasminogen Activator Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Tissue Plasminogen Activator Sales Breakdown by Type (2016-2021)

2 Global Tissue Plasminogen Activator Market Competition by Company
2.1 Global Top Players by Tissue Plasminogen Activator Sales (2016-2021)
2.2 Global Top Players by Tissue Plasminogen Activator Revenue (2016-2021)
2.3 Global Top Players Tissue Plasminogen Activator Price (2016-2021)
2.4 Global Top Manufacturers Tissue Plasminogen Activator Manufacturing Base Distribution, Sales Area, Product Type
2.5 Tissue Plasminogen Activator Market Competitive Situation and Trends
2.5.1 Tissue Plasminogen Activator Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Tissue Plasminogen Activator Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tissue Plasminogen Activator as of 2020)
2.7 Date of Key Manufacturers Enter into Tissue Plasminogen Activator Market
2.8 Key Manufacturers Tissue Plasminogen Activator Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Tissue Plasminogen Activator Status and Outlook by Region
3.1 Global Tissue Plasminogen Activator Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Tissue Plasminogen Activator Historic Market Size by Region
3.2.1 Global Tissue Plasminogen Activator Sales in Volume by Region (2016-2021)
3.2.2 Global Tissue Plasminogen Activator Sales in Value by Region (2016-2021)
3.2.3 Global Tissue Plasminogen Activator Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Tissue Plasminogen Activator Forecasted Market Size by Region
3.3.1 Global Tissue Plasminogen Activator Sales in Volume by Region (2022-2027)
3.3.2 Global Tissue Plasminogen Activator Sales in Value by Region (2022-2027)
3.3.3 Global Tissue Plasminogen Activator Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global Tissue Plasminogen Activator by Application
4.1 Tissue Plasminogen Activator Market Segment by Application
4.1.1 Ischemic Stroke
4.1.2 Pulmonary Embolism
4.1.3 Myocardial Infarction
4.1.4 Others
4.2 Global Tissue Plasminogen Activator Market Size by Application
4.2.1 Global Tissue Plasminogen Activator Market Size Overview by Application (2016-2027)
4.2.2 Global Tissue Plasminogen Activator Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Tissue Plasminogen Activator Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Tissue Plasminogen Activator Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Tissue Plasminogen Activator Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Tissue Plasminogen Activator Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Tissue Plasminogen Activator Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Tissue Plasminogen Activator Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Tissue Plasminogen Activator Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Tissue Plasminogen Activator Sales Breakdown by Application (2016-2021)
4.3.2 Europe Tissue Plasminogen Activator Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Tissue Plasminogen Activator Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Tissue Plasminogen Activator Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Tissue Plasminogen Activator Sales Breakdown by Application (2016-2021)

5 North America Tissue Plasminogen Activator by Country
5.1 North America Tissue Plasminogen Activator Historic Market Size by Country
5.1.1 North America Tissue Plasminogen Activator Sales in Volume by Country (2016-2021)
5.1.2 North America Tissue Plasminogen Activator Sales in Value by Country (2016-2021)
5.2 North America Tissue Plasminogen Activator Forecasted Market Size by Country
5.2.1 North America Tissue Plasminogen Activator Sales in Volume by Country (2022-2027)
5.2.2 North America Tissue Plasminogen Activator Sales in Value by Country (2022-2027)

6 Europe Tissue Plasminogen Activator by Country
6.1 Europe Tissue Plasminogen Activator Historic Market Size by Country
6.1.1 Europe Tissue Plasminogen Activator Sales in Volume by Country (2016-2021)
6.1.2 Europe Tissue Plasminogen Activator Sales in Value by Country (2016-2021)
6.2 Europe Tissue Plasminogen Activator Forecasted Market Size by Country
6.2.1 Europe Tissue Plasminogen Activator Sales in Volume by Country (2022-2027)
6.2.2 Europe Tissue Plasminogen Activator Sales in Value by Country (2022-2027)

7 Asia-Pacific Tissue Plasminogen Activator by Region
7.1 Asia-Pacific Tissue Plasminogen Activator Historic Market Size by Region
7.1.1 Asia-Pacific Tissue Plasminogen Activator Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Tissue Plasminogen Activator Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Tissue Plasminogen Activator Forecasted Market Size by Region
7.2.1 Asia-Pacific Tissue Plasminogen Activator Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Tissue Plasminogen Activator Sales in Value by Region (2022-2027)

8 Latin America Tissue Plasminogen Activator by Country
8.1 Latin America Tissue Plasminogen Activator Historic Market Size by Country
8.1.1 Latin America Tissue Plasminogen Activator Sales in Volume by Country (2016-2021)
8.1.2 Latin America Tissue Plasminogen Activator Sales in Value by Country (2016-2021)
8.2 Latin America Tissue Plasminogen Activator Forecasted Market Size by Country
8.2.1 Latin America Tissue Plasminogen Activator Sales in Volume by Country (2022-2027)
8.2.2 Latin America Tissue Plasminogen Activator Sales in Value by Country (2022-2027)

9 Middle East and Africa Tissue Plasminogen Activator by Country
9.1 Middle East and Africa Tissue Plasminogen Activator Historic Market Size by Country
9.1.1 Middle East and Africa Tissue Plasminogen Activator Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Tissue Plasminogen Activator Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Tissue Plasminogen Activator Forecasted Market Size by Country
9.2.1 Middle East and Africa Tissue Plasminogen Activator Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Tissue Plasminogen Activator Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in Tissue Plasminogen Activator Business
10.1 Bayer AG
10.1.1 Bayer AG Corporation Information
10.1.2 Bayer AG Introduction and Business Overview
10.1.3 Bayer AG Tissue Plasminogen Activator Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Bayer AG Tissue Plasminogen Activator Products Offered
10.1.5 Bayer AG Recent Development
10.2 Genentech
10.2.1 Genentech Corporation Information
10.2.2 Genentech Introduction and Business Overview
10.2.3 Genentech Tissue Plasminogen Activator Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Bayer AG Tissue Plasminogen Activator Products Offered
10.2.5 Genentech Recent Development
10.3 Sigma-Aldrich
10.3.1 Sigma-Aldrich Corporation Information
10.3.2 Sigma-Aldrich Introduction and Business Overview
10.3.3 Sigma-Aldrich Tissue Plasminogen Activator Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Sigma-Aldrich Tissue Plasminogen Activator Products Offered
10.3.5 Sigma-Aldrich Recent Development
10.4 Taj Pharmaceuticals
10.4.1 Taj Pharmaceuticals Corporation Information
10.4.2 Taj Pharmaceuticals Introduction and Business Overview
10.4.3 Taj Pharmaceuticals Tissue Plasminogen Activator Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Taj Pharmaceuticals Tissue Plasminogen Activator Products Offered
10.4.5 Taj Pharmaceuticals Recent Development
10.5 Zydus Cadila Healthcare
10.5.1 Zydus Cadila Healthcare Corporation Information
10.5.2 Zydus Cadila Healthcare Introduction and Business Overview
10.5.3 Zydus Cadila Healthcare Tissue Plasminogen Activator Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Zydus Cadila Healthcare Tissue Plasminogen Activator Products Offered
10.5.5 Zydus Cadila Healthcare Recent Development
10.6 Calbiochem
10.6.1 Calbiochem Corporation Information
10.6.2 Calbiochem Introduction and Business Overview
10.6.3 Calbiochem Tissue Plasminogen Activator Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Calbiochem Tissue Plasminogen Activator Products Offered
10.6.5 Calbiochem Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Tissue Plasminogen Activator Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Tissue Plasminogen Activator Industrial Chain Analysis
11.4 Tissue Plasminogen Activator Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Tissue Plasminogen Activator Distributors
12.3 Tissue Plasminogen Activator Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
  • FORMAT: PDF
  • PUBLISHED DATE: Jun, 2021
  • NO OF PAGES: 140